AlzChem Group AG
ALZCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $554 | $541 | $542 | $422 |
| % Growth | 2.5% | -0.3% | 28.4% | – |
| Cost of Goods Sold | $194 | $242 | $259 | $154 |
| Gross Profit | $361 | $299 | $283 | $268 |
| % Margin | 65.1% | 55.3% | 52.1% | 63.5% |
| R&D Expenses | $11 | $11 | $11 | $10 |
| G&A Expenses | $12 | $13 | $11 | $11 |
| SG&A Expenses | $32 | $34 | $40 | $29 |
| Sales & Mktg Exp. | $20 | $21 | $28 | $18 |
| Other Operating Expenses | $240 | $0 | -$10 | -$8 |
| Operating Expenses | $283 | $161 | $252 | $231 |
| Operating Income | $78 | $143 | $61 | $38 |
| % Margin | 14.1% | 26.5% | 11.3% | 9% |
| Other Income/Exp. Net | -$3 | -$95 | -$20 | -$26 |
| Pre-Tax Income | $75 | $48 | $41 | $37 |
| Tax Expense | $21 | $13 | $11 | $9 |
| Net Income | $54 | $35 | $30 | $28 |
| % Margin | 9.8% | 6.4% | 5.5% | 6.5% |
| EPS | 5.31 | 3.4 | 2.97 | 2.72 |
| % Growth | 56.2% | 14.5% | 9.2% | – |
| EPS Diluted | 5.31 | 3.4 | 2.97 | 2.72 |
| Weighted Avg Shares Out | 10 | 10 | 10 | 10 |
| Weighted Avg Shares Out Dil | 10 | 10 | 10 | 10 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $0 | $8 | $1 |
| Interest Expense | $6 | $8 | $3 | $2 |
| Depreciation & Amortization | $26 | $26 | $26 | $24 |
| EBITDA | $107 | $82 | $70 | $63 |
| % Margin | 19.4% | 15.1% | 12.9% | 14.8% |